Amarin Corp Plc (AMRN)

[SocialBoom]

JL, you are one of the posters I consider an expert on many topics. It's ok if you disagree with me on this. That said, trading is not about experts, or clinicians.

In order to move and more importantly sustain after a move we need shares to move from retail to institutions tightening the trading band and the ability to cover a short.

All the issues you listed are "known". The only unknowns are what will FDA approve as an expanded label exactly, and can AMRN support the demand that comes from that.

I believe funds who know and understand every aspect of this trade are indeed hung on the AMRN API availability issue.

The sooner JT addresses it showing contingency contracts that assure the supply the better.